Ikuya Miki

1.7k total citations
65 papers, 1.1k citations indexed

About

Ikuya Miki is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Ikuya Miki has authored 65 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Surgery, 26 papers in Pulmonary and Respiratory Medicine and 18 papers in Oncology. Recurrent topics in Ikuya Miki's work include Gastric Cancer Management and Outcomes (19 papers), Helicobacter pylori-related gastroenterology studies (19 papers) and Esophageal Cancer Research and Treatment (14 papers). Ikuya Miki is often cited by papers focused on Gastric Cancer Management and Outcomes (19 papers), Helicobacter pylori-related gastroenterology studies (19 papers) and Esophageal Cancer Research and Treatment (14 papers). Ikuya Miki collaborates with scholars based in Japan, United States and Greece. Ikuya Miki's co-authors include Takao Tamura, Toshiyuki Sakaeda, Nobuo Aoyama, Tsutomu Nakamura, Daisuke Shirasaka, Masato Kasuga, Takeshi Azuma, Shigeto Mizuno, Yoshinori Morita and Masaru Yoshida and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Ikuya Miki

61 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ikuya Miki Japan 19 548 323 309 196 194 65 1.1k
Junichi Iwamoto Japan 17 553 1.0× 138 0.4× 307 1.0× 286 1.5× 168 0.9× 39 1.1k
Christoph von Ritter Germany 16 394 0.7× 265 0.8× 107 0.3× 135 0.7× 159 0.8× 21 890
G.M. Murphy United Kingdom 20 374 0.7× 295 0.9× 337 1.1× 144 0.7× 70 0.4× 57 1.1k
Chung Hong Kong 18 336 0.6× 109 0.3× 72 0.2× 305 1.6× 152 0.8× 53 936
Mitsuyuki Murano Japan 18 554 1.0× 307 1.0× 304 1.0× 313 1.6× 243 1.3× 59 1.6k
T.C. Northfield United Kingdom 21 581 1.1× 360 1.1× 348 1.1× 97 0.5× 149 0.8× 50 1.2k
Tetsuya Okayama Japan 25 425 0.8× 391 1.2× 730 2.4× 543 2.8× 212 1.1× 77 1.8k
Satoshi Tokioka Japan 15 539 1.0× 338 1.0× 56 0.2× 97 0.5× 395 2.0× 48 940
Angelo Burlina Italy 16 303 0.6× 192 0.6× 220 0.7× 199 1.0× 37 0.2× 89 1.1k
Mae F. Go United States 19 832 1.5× 254 0.8× 69 0.2× 115 0.6× 205 1.1× 52 1.1k

Countries citing papers authored by Ikuya Miki

Since Specialization
Citations

This map shows the geographic impact of Ikuya Miki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ikuya Miki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ikuya Miki more than expected).

Fields of papers citing papers by Ikuya Miki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ikuya Miki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ikuya Miki. The network helps show where Ikuya Miki may publish in the future.

Co-authorship network of co-authors of Ikuya Miki

This figure shows the co-authorship network connecting the top 25 collaborators of Ikuya Miki. A scholar is included among the top collaborators of Ikuya Miki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ikuya Miki. Ikuya Miki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kobayashi, Satoshi, Akihiro Ohba, Junki Mizusawa, et al.. (2024). 1527P GnP vs mFOLFIRINOX or S-IROX in metastatic pancreatic cancer: 1-year follow-up updated data from the GENERATE (JCOG1611). Annals of Oncology. 35. S932–S932. 1 indexed citations
4.
Sakai, Arata, Atsuhiro Masuda, Takaaki Eguchi, et al.. (2023). A novel fully covered metal stent for unresectable malignant distal biliary obstruction: results of a multicenter prospective study. Clinical Endoscopy. 57(3). 375–383. 1 indexed citations
5.
Takegawa, Naoki, Michiko Nishikawa, Aya Sakai, et al.. (2021). Pretreatment Glasgow prognostic score as a predictor of outcomes in nivolumab-treated patients with advanced gastric cancer. PLoS ONE. 16(2). e0247645–e0247645. 15 indexed citations
6.
Kadoyama, Kaori, J.B. Brown, Tsutomu Nakamura, et al.. (2015). Antipsychotics-Associated Serious Adverse Events in Children: An Analysis of the FAERS Database. International Journal of Medical Sciences. 12(2). 135–140. 33 indexed citations
7.
Tsumura, Hidetaka, Takeshi Sakamoto, Kazutoshi Tobimatsu, et al.. (2014). Constrictive pericarditis caused by a pericardial-occupying tumor due to esophageal cancer. Clinical Journal of Gastroenterology. 7(3). 243–246. 2 indexed citations
8.
Omatsu, H., Akiko Kuwahara, Motohiro Yamamori, et al.. (2013). TNF-α -857C>T Genotype is Predictive of Clinical Response after Treatment with Definitive 5-Fluorouracil/cisplatin-based Chemoradiotherapy in Japanese Patients with Esophageal Squamous Cell Carcinoma. International Journal of Medical Sciences. 10(12). 1755–1760. 6 indexed citations
9.
Ishida, Tsukasa, Ikuya Miki, Toshihito Tanahashi, et al.. (2013). Effect of 18β-glycyrrhetinic acid and hydroxypropyl γcyclodextrin complex on indomethacin-induced small intestinal injury in mice. European Journal of Pharmacology. 714(1-3). 125–131. 33 indexed citations
10.
Kadoyama, Kaori, Ikuya Miki, Takao Tamura, et al.. (2012). Adverse Event Profiles of 5-Fluorouracil and Capecitabine: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS, and Reproducibility of Clinical Observations. International Journal of Medical Sciences. 9(1). 33–39. 54 indexed citations
11.
Ando, Takashi, Shigeto Mizuno, Tsukasa Ishida, et al.. (2012). Plasma ghrelin isoforms and gastric ghrelin O-acyltransferase expression are influenced by Helicobacter pylori status. Nutrition. 28(10). 967–972. 9 indexed citations
12.
Tamura, Takao, Akiko Kuwahara, Kaori Kadoyama, et al.. (2011). Effects of Bolus Injection of 5-Fluorouracil on Steady-State Plasma Concentrations of 5-Fluorouracil in Japanese Patients with Advanced Colorectal Cancer. International Journal of Medical Sciences. 8(5). 406–412. 11 indexed citations
13.
Masuda, Atsuhiro, Shin Nishiumi, Kazuyuki Kawakami, et al.. (2011). AP1B plays an important role in intestinal tumorigenesis with the truncating mutation of an APC gene. International Journal of Cancer. 130(5). 1011–1020. 10 indexed citations
14.
Kuwahara, Akiko, Motohiro Yamamori, Kaori Kadoyama, et al.. (2011). Effects of plasma concentrations of 5-fluorouracil on long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma. Journal of Experimental & Clinical Cancer Research. 30(1). 94–94. 5 indexed citations
15.
Mizuno, Shigeto, Ikuya Miki, Tsukasa Ishida, et al.. (2010). Prescreening of a High-Risk Group for Gastric Cancer by Serologically Determined Helicobacter pylori Infection and Atrophic Gastritis. Digestive Diseases and Sciences. 55(11). 3132–3137. 91 indexed citations
16.
Yoshida, S, Nobunao Ikehara, Nobuo Aoyama, et al.. (2007). Relationship of BRAF mutation, morphology, and apoptosis in early colorectal cancer. International Journal of Colorectal Disease. 23(1). 7–13. 5 indexed citations
17.
Toyoda, Masanori, Daisuke Shirasaka, Nobuo Aoyama, et al.. (2006). Impact of Helicobacter pylori Eradication Therapy on Histologic Change in the Distal Esophagus. Helicobacter. 11(4). 217–223. 3 indexed citations
18.
Shirasaka, Daisuke, Nobuo Aoyama, Ikuya Miki, et al.. (2006). Effects of Helicobacter pylori eradication therapy on gastric emptying measured using the 13C‐octanoic acid breath test and the acetaminophen method. Journal of Gastroenterology and Hepatology. 21(5). 824–830. 5 indexed citations
19.
Miki, Ikuya, Nobuo Aoyama, Daisuke Shirasaka, et al.. (2005). Levofloxacin- versus metronidazole-based rescue therapy for infection in Japan. Digestive and Liver Disease. 37(11). 821–825. 55 indexed citations
20.
Miki, Ikuya, Nobuo Aoyama, Toshiyuki Sakai, et al.. (2003). Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan. European Journal of Gastroenterology & Hepatology. 15(1). 27–33. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026